Ecron Acunova-Pharmaceuticals & Healthcare-Deals and Alliances Profile
- GDPH117236D
- Pages: 20
- July 2017
- Total Views:1276
- Region : Asia
- GlobalData
- Equity Research Report

Details
Summary
Ecron Acunova (EA), a subsidiary of Take Solutions Ltd. is a clinical research organization (CRO) serving big pharma companies locally. It offers clinical trial management, clinical data management services. Its services include bioavailability and bioequivalence services, Phase I to IV clinical trials, peri approval studies, PMS, rescue studies, clinical data management and biostatistics, medical writing, regulatory affairs, pharmacovigilance, and central laboratory. Ecron provides bioavailability and bioequivalence services such as consulting, IP import and sample export, protocol design, ethics committee submissions, safety screening and bio analytical testing. The company serves pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. It operates in South East Asia, Central and Nordic Europe and North America. Ecron Acunova is headquartered in Bangalore, Karnataka, India.
Ecron Acunova-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ecron Acunova, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Manipal Acunova Plans To Raise Up To USD30 Million In Venture Financing 11
Partnerships 11
Ecron Acunova Forms Joint venture With Jamjuree Innovations 11
Acquisition 12
TAKE Solutions to Acquire Ecron Acunova 12
Ecron Acunova Acquires Majority Stake In aCROnordic 13
Ecron Acunova-Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Other Significant Developments 19
Jun 09, 2017: Ecron Acunova to offer end-to-end capabilities as 'Navitas Life Sciences 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List Of Figure
List of Figures
Ecron Acunova, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
List Of Table
List of Tables
Ecron Acunova, Pharmaceuticals & Healthcare, Key Facts 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Manipal Acunova Plans To Raise Up To USD30 Million In Venture Financing 11
Ecron Acunova Forms Joint venture With Jamjuree Innovations 11
TAKE Solutions to Acquire Ecron Acunova 12
Ecron Acunova Acquires Majority Stake In aCROnordic 13
Ecron Acunova, Key Competitors 15
Ecron Acunova, Key Employees 16
Ecron Acunova, Other Locations 17
Ecron Acunova, Subsidiaries 17
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Ecron Acunova, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Ecron Acunova (EA), a subsidiary of Take Solutions Ltd. is a clinical research organization (CRO) serving big pharma companies locally. It offers clinical trial management, clinical data management services. Its services include bioavailability and bioequivalence services, Phase I to IV clinical trials, peri approval studies, PMS, rescue studies, clinical data management and biostatistics, medical writing, regulatory affairs, pharmacovigilance, and central laboratory. Ecron provides bioavailability and bioequivalence services such as consulting, IP import and sample export, protocol design, ethics committee submissions, safety screening and bio analytical testing. The company serves pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. It operates in South East Asia, Central and Nordic Europe and North America. Ecron Acunova is headquartered in Bangalore, Karnataka, India.
Ecron Acunova-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ecron Acunova, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Manipal Acunova Plans To Raise Up To USD30 Million In Venture Financing 11
Partnerships 11
Ecron Acunova Forms Joint venture With Jamjuree Innovations 11
Acquisition 12
TAKE Solutions to Acquire Ecron Acunova 12
Ecron Acunova Acquires Majority Stake In aCROnordic 13
Ecron Acunova-Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Other Significant Developments 19
Jun 09, 2017: Ecron Acunova to offer end-to-end capabilities as 'Navitas Life Sciences 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List Of Figure
List of Figures
Ecron Acunova, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
List Of Table
List of Tables
Ecron Acunova, Pharmaceuticals & Healthcare, Key Facts 1
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ecron Acunova, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ecron Acunova, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ecron Acunova, Deals By Therapy Area, 2011 to YTD 2017 8
Ecron Acunova, Medical Devices Deals, 2011 to YTD 2017 9
Ecron Acunova, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Manipal Acunova Plans To Raise Up To USD30 Million In Venture Financing 11
Ecron Acunova Forms Joint venture With Jamjuree Innovations 11
TAKE Solutions to Acquire Ecron Acunova 12
Ecron Acunova Acquires Majority Stake In aCROnordic 13
Ecron Acunova, Key Competitors 15
Ecron Acunova, Key Employees 16
Ecron Acunova, Other Locations 17
Ecron Acunova, Subsidiaries 17
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Ecron Acunova, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.